Adoptive immunotherapy of cancer with polyclonal, 10(8)-fold hyperexpanded, CD4(+ )and CD8(+ )T cells

T cell-mediated cancer immunotherapy is dose dependent and optimally requires participation of antigen-specific CD4(+ )and CD8(+ )T cells. Here, we isolated tumor-sensitized T cells and activated them in vitro using conditions that led to greater than 10(8)-fold numerical hyperexpansion of either th...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Li-Xin, Huang, Wen-Xin, Graor, Hallie, Cohen, Peter A, Kim, Julian A, Shu, Suyu, Plautz, Gregory E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535812/
https://www.ncbi.nlm.nih.gov/pubmed/15566571
http://dx.doi.org/10.1186/1479-5876-2-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC535812/
https://www.ncbi.nlm.nih.gov/pubmed/15566571
http://dx.doi.org/10.1186/1479-5876-2-41

Ejemplares similares